[The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
作者信息
Larsen Christian-Jacques
出版信息
Bull Cancer. 2011 Jan;98(1):10.
PMID:21591298
Abstract
摘要
相似文献
1
[The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
Bull Cancer. 2011 Jan;98(1):10.
2
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Cell. 2004 Nov 24;119(5):591-602. doi: 10.1016/j.cell.2004.11.022.
3
Polymorphic variants in the p53 pathway.
Cell Death Differ. 2006 Jun;13(6):916-20. doi: 10.1038/sj.cdd.4401907.
4
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.
Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010.
5
Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
DNA Cell Biol. 2013 Jan;32(1):19-27. doi: 10.1089/dna.2012.1718. Epub 2012 Dec 4.
6
MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study.
Ann Clin Lab Sci. 2014 Fall;44(4):449-54.
7
Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Int J Oncol. 2003 Feb;22(2):383-9.
8
Association of breast cancer outcome with status of p53 and MDM2 SNP309.
J Natl Cancer Inst. 2006 Jul 5;98(13):911-9. doi: 10.1093/jnci/djj245.
9
The p53 mutation "gradient effect" and its clinical implications.
J Cell Physiol. 2007 Nov;213(2):370-3. doi: 10.1002/jcp.21217.
10
A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.
Cancer Res. 2007 Mar 15;67(6):2757-65. doi: 10.1158/0008-5472.CAN-06-2656.
Zotero 插件